“Most relevant and largest opportunity for networking “ ABCAM
Organisations with a commercial interest are invited to exhibit and experience an environment rich in networking opportunities with plenty of occasions to engage in business conversations. We understand that interaction is the main focus and so throughout the conference we have set up dedicated activities to help facilitate dialogue between our exhibitors and delegates.
Over 11 hours of dedicated networking time has been set aside to help you engage in conversations to develop relationships. Activities include;
|NEW: 121 Meeting Facility via PartneringONE
|NEW: BPI Live Lab Tour
|Spotlight presentation within the main programme
|Strategic Round Table Debates
|Joint Exhibition & Delegate Lunch Sessions
|1st Annual Cell Culture Club Drinks Reception
Tailored sponsorship/exhibitor package for SME companies:
BPI European is all about recognising the next steps in biopharm innovation and we are pleased to offer new SME companies the option to showcase their work.
Conditions apply and exhibitors must meet SME criteria. For further details please contact email@example.com
For Sponsorship & Exhibition Enquiries:
For details about exhibiting and sponsorship opportunities please contact email: firstname.lastname@example.org,
Tel: +44 (0) 207 017 5011
Novasep develops, markets and operates innovative technologies to produce active molecules for the life sciences industry. Our research and development teams constantly innovate to design the next generation of processing in order to improve product quality and safety with lower production costs.
The applications of Novasep’s offering cover the pharmaceutical, biopharmaceutical, food, functional ingredient and bio-industries markets.
Our global solution for biopharmaceutical manufacturing includes:
With Novasep, you will benefit from our process intelligence:
GE Healthcare Life Sciences provides a broad range of products and services for biomolecule separations at all scales. Chief products include: • ÄKTAdesign™ chromatography systems and BioProcess™ media • Filtration systems and devices • Wave Bioreactor™ and mixers • Cell separation for isolating and purifying cells, viruses, and sub-cellular particles • Fast Trak™ BioPharma Services. Our products are used in the manufacture of the majority of all FDA-approved biopharmaceuticals on the market. GE Healthcare Life Sciences is a part of GE Healthcare, a General Electric company with more than 42,000 employees, providing transformational medical technologies that are shaping a new age of patient care.
BD Biosciences is a life sciences leader with more than 50 years of expertise in cell biology products and services. The Advanced Bioprocessing strategic platform developed products currently being used as critical components in the production of some of the most widely used drugs and vaccines on the global market today. BD Biosciences - Advanced Bioprocessing (BDB-AB) is playing a major role in biopharmaceutical drug production, enabling customers large and small to have a tremendous impact on the future of human healthcare. BDB-AB‘s novel portfolio of hydrolysates, cell culture media supplements and services is the optimal choice for your mammalian cell culture and bacterial fermentation bioprocessing needs.
For more information visit www.bdbiosciences.com/advbio
Irvine Scientific is an innovative, large capacity cell culture media manufacturing company that supplies biotech and biopharmaceutical markets worldwide. Our commercial manufacturing program offers: cGMP compliant operations, custom packaging configurations, lot-to-lot consistency, regulatory filing support, rapid prototype manufacturing and more.
Cell Culture Media - Quality In Quantity.
Gallus BioPharmaceuticals delivers end-to-end biologics process development and cGMP drug manufacturing for pre-clinical, clinical and commercial stages for pharmaceutical, biotechnology and government organizations.
Unlike conventional contract manufactures, we empower you – our customers – by accelerating your time to market through personal symbiotic collaboration and virtual ownership models driven by advanced single-use technologies. Our sweeping approval from every major regulatory body across the globe, including the FDA, EMA, HealthCanada, ANVISA and PMDA, ultimately makes us the ideal partner for your entire suite of contract manufacturing needs.
From research and development to full-scale manufacturing, Parker domnick hunter provides biopharmaceutical producers with high purity processing solutions that speed up development times, increase efficiency and safety, and guarantee reproducible product quality. With the addition of SciLog, Parker domnick hunter offer an extensive single-use bioprocessing portfolio combining filtration and separation, disposable bag systems and sensors, and automated single-use solutions. Parker domnick hunter’s single-use product range is supported by a dedicated international team of biopharmaceutical specialists.
SGS Life Science Services is a leading contract service organization providing clinical research, pharmaceutical development, biologics characterization, utilities qualification, biosafety, and quality control testing. With a strong focus on biologics and vaccines, SGS operates 29 facilities in 15 countries and represents the broadest, wholly-owned global network of contract analytical laboratories. For more information visit: www.sgs.com/biopharma
In just a few short years, Eppendorf AG has strategically positioned
itself as a leader in the bioprocess equipment market.
With a comprehensive offering of single-use and traditional products, and
working volumes of 35 mL – 2400L, the Eppendorf bioprocess portfolio can
satisfy the demands of process development through production.
TAP Biosystems provides advanced automation systems and services to improve productivity in life science research, development & production.
TAP will be showcasing:
AB SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company's global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug iscovery and development, food and environmental testing, forensics and clinical research. With 40 years of proven innovation, AB SCIEX excels by listening to and understanding the ever-evolving needs of its
customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information about the company, go to www.absciex.com/company/overview.
Repligen Corporation is a global life sciences company focused on the
development, production, and commercialization of products used in the process of manufacturing biological drugs. We are the world’s leading manufacturer of Protein A ligands, and also produce cell culture growth factors, Protein A resins, Protein A ELISA kits, and OPUS® pre-packed disposable chromatography columns.
BioReliance Corporation is a leading provider of cost-effective contract services
to the pharmaceutical and biopharmaceutical industries, offering more than 1,000 tests or services related to biologics safety testing, specialized toxicology and animal health diagnostics. Our capabilities include a broad spectrum of cGMP- and GLP-compliant virological, immunological, molecular biology and microbial testing services.
ASI is a leading global provider of advanced single-use systems for the Life Sciences Industries. ASI’s systems and high-quality services provide the flexibility to maximize efficiencies, minimize costs and alleviate risks in the production of bio-pharmaceutical
processes. Closely allied with industry suppliers, ASI’s custom configured solutions are unique to each customer’s specifications.
Shaping discovery. Improving life. As a brand of Thermo Fisher Scientific, Life Technologies believes in the power of science to transform lives. To support scientists
worldwide, we offer high-quality, innovative life science solutions—from everyday essentials to instruments—for every lab, every application. Our products have the potential to address some of the most pressing challenges of the 21st century: clean water and safe food, improved healthcare, protected genetic diversity, and a healthy environment.
Life Technologies, now a brand of Thermo Fisher Scientific, traces its roots back to 1962 with the creation of Grand Island Biological Company (GIBCO) in Grand Island, New York, making serum harvested from horses raised on their land. The original Life Technologies, Inc., a subsidiary of Dexter Corp., was founded in 1983 by the merger of Bethesda Research Laboratories, Inc. and GIBCO Corporation. In 2000, Life Technologies was bought out by Invitrogen, who gradually discontinued the use of the name Life Technologies. Eight years later, following the merger of Invitrogen Corporation and Applied Biosystems, Inc., the company resurrected the name to create the new Life Technologies Corp. In 2014, Life Technologies became the fourth premier brand within Thermo Fisher, the world leader in
Asahi Kasei Bioprocess, one of the world’s leading manufacturers in virus removal filtration “Planova Filters”, is now providing innovative upstream and downstream product line-up to enhance time and cost efficient process set up in biotherapeutic drug products with science-based technologies and world-wide support networks.
Pall Life Sciences
Pall Life Sciences provides cutting-edge products and services to meet the demanding needs of customers discovering, developing and producing biotech drugs, vaccines and classic pharmaceuticals. Pall is a leading provider of separation systems and single-use filtration and purification technologies to pharmaceutical and biotechnology companies to support faster development of new drugs and vaccines that are safer and require less energy and water to produce.
Merck Millipore is the Life Science division of Merck KGaA, Darmstadt, Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.
JSR is a $4 billion multinational and your partner of excellence to deliver solutions in the field of downstream purification. JSR has been supplying high performance particles and polymer based products for the In Vitro Diagnostics and Life Science industries for the last 30 years. Our product line is constantly in development to meet your ever changing requirements. In close collaboration we create value by developing state-of-the-art products that meet the timing, performance, quality and cost requirements of our customers.
As the leading manufacturer of pumps and pump systems, LEWA assists you during the development of complete solutions that are matched exactly to your process requirements.
We supply systems with in-house engineering, which meet all requirements relevant to the pharma and biotech industry (cGMP, GAMP, 21 CFR, etc.). We also offer complete documentation, acceptance tests, validation/qualification, installation and start-up services.
System solutions from LEWA are found in these markets in numerous applications, from the metering of fluids, dilution of buffers or concentrates, dispersing and mixing jobs right up to microfiltration and ultrafiltration systems. These require precise volume flows and exact conformance to specific process conditions.
FrieslandCampina Domo, offer a full range of animal free protein hydrolysates. These are used as media supplements in Biopharmaceutical culture media and help boost production output. We have over 30 years of technical expertise in the manufacturing of high performing protein hydrolysates. With our state-of-the-art pilot plant and manufacturing facility, as well as, analytical laboratories located in Delhi, NY and R&D facilities in Wageningen, The Netherlands, we are ready to share our knowledge and provide our high performance hydrolysates to enhance your cell culture process
Based in Darlington UK, the National Biologics Manufacturing Centre will focus on the development of next generation biologics manufacturing. The facility will consist of analytical, process, development and near GMP laboratories. The NBMC will address the development and adoption of innovative processes and analytical technologies to demonstrate rapid manufacturability and formability. For more details please visit www.uk-cpi.com
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically.
Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions.”
Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approx. 3000 people, and in 2012 earned sales revenue of 544.0 million euros according to preliminary figures.
Lonza Custom Development and Manufacturing has made a strong commitment to the Pharma and Biotech Industry over the last 30+ years. We are dedicated to helping emerging and established companies improve and advance their therapeutic products for successful commercialization. Our diverse chemical and biotechnology platforms combined
with our complete set of Development Services and industry-leading Manufacturing processes, and enable you to optimize your time and costs throughout the pharmaceutical pipeline.
Lonza has the know-how and experience to handle almost any pharmaceutical or biotechnology challenge. We have industry leading experts specializing in active pharmaceutical ingredients (APIs), highly potent APIs, advanced intermediates, fine chemicals, antibody drug conjugates, peptides, vaccines, plasmid DNA, recombinant novel proteins, monoclonal antibodies, antibody fragments, cell-based therapeutics and
viral-based therapeutics. Combined with our global footprint, Lonza is well positioned to be your partner of choice throughout your therapeutic development journey.
Cytovance® Biologics is a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. In addition to its cGMP manufacturing services, the company offers process development, cell line development, cGMP cell banking and storage, and support
services from its Oklahoma City state-of-the-art facilities.
One Nucleus is a not-for-profit membership organisation for international life science and healthcare companies and the largest of its kind in Europe. The company is based in Cambridge UK and London, at the heart of Europe's largest cluster. The 470 members include pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial Service Providers.
Technology Networks was established over 10 years ago with the aim of providing informative websites for life science professionals. From our UK headquarters near Sudbury, in Suffolk, we run, update and provide an outstanding web-based information solution for those working within the Life Science and Drug Discovery community.
Since its humble beginnings running just one website based on Combinatorial Chemistry, Technology Networks has expanded its portfolio to include over 30 communities, all of which are available through TechnologyNetworks.com.
European Biopharmaceutical Review (EBR) is a magazine dedicated to the biopharmaceutical and biotech industries. Each quarterly edition features articles from key opinion leaders on research, drug discovery and development, biomanufacturing, outsourcing and more on the science and business of the sectors. EBR also features insightful interviews, reviews and event information to form an appealing B2B platform. Read the latest articles and subscribe at http://www.samedanltd.com/magazine/12.